Whilst TNF-α is not ubiquitously raised in COPD [6] and anti-TNF-α treatments are not efficacious in a generalised COPD population [7], single nucleotide polymorphisms (SNPs) in the TNF-A gene have been identified that might enhance susceptibility to COPD by increasing inflammatory output. This evidence concerns the gene TNF and chronic obstructive pulmonary disease.